← All peptides

BPC-157

Research Use Only
peptideSubcutaneous injectionOral

A healing compound originally found in stomach juice. It's one of the most versatile peptides out there -- great for repairing damaged tissue, healing the gut lining, and calming down inflammation. Arguably the most well-studied healing peptide available.

What to Expect

1

Week 1–2

Reduced inflammation and pain at injury site. Mild improvement in gut symptoms if taken orally. Some users report faster wound closure.

2

Week 3–6

Noticeable tissue repair — tendons feel stronger, joint pain diminishes. Gut lining healing becomes apparent with reduced bloating and food sensitivities.

3

Week 8+

Significant structural repair of tendons, ligaments, and gut mucosa. Chronic injuries may reach full recovery. Benefits tend to plateau after 8-12 weeks.

Common Side Effects

Mild nausea (oral)Injection site rednessDizziness (rare)Mild headache
Tolerance: None observed — efficacy maintained throughout cycle
Cycling: 4-8 weeks on, 2-4 weeks off. Some protocols run 12 weeks for chronic injuries.

Scientific Overview

Body Protection Compound-157 is a synthetic pentadecapeptide (15 amino acids) derived from human gastric juice protein BPC. It operates through multiple mechanisms including upregulation of growth factor expression (EGF, HGF, VEGF), activation of the FAK-paxillin pathway promoting angiogenesis, and modulation of the nitric oxide (NO) system. Studies demonstrate cytoprotective activity across gastrointestinal, musculoskeletal, and neurological tissues. BPC-157 has shown particular efficacy in tendon-to-bone healing models, where it accelerates collagen organization and mechanical strength recovery.

Dosing

250-500 mcg once or twice daily. Inject subq near the injury site, or take it orally if you're targeting gut issues. Typical cycle is 4-6 weeks.

Practical Guide

Reconstitution

Mix 5mg vial with 2mL bacteriostatic water (BAC water). Each 0.1mL = 250mcg.

Storage

Refrigerate after reconstitution. Use within 30 days. Store lyophilized powder at room temperature or refrigerated.

Injection Sites

Subcutaneous near injury siteLower abdomen (systemic)Outer thigh

Inject as close to the injury as possible for localized effects. Use 29-31g insulin syringe. Rotate injection sites.

Timing

Twice daily dosing (morning and evening) provides best coverage. No specific time-of-day preference.

Food

No significant food interactions for injectable. Oral capsules best taken on empty stomach for gut-targeted effects.

Benefit Profile

🫁 Gut Health
10/10
🩹 Injury Healing
10/10
🧊 Inflammation
8/10
💪 Muscle Growth
4/10
🧠 Brain & Cognition
3/10
😌 Mood & Anxiety
3/10

Medical Considerations

Medical oversight recommendedNot safe during pregnancy

Contraindications

  • Active cancer or history of cancer (theoretical growth factor concern)
  • Pregnancy/nursing
  • Children under 18

Drug Interactions

May potentiate effects of NSAIDs on gastric healingTheoretical interaction with anticoagulants (affects NO system)

Recommended Monitoring

  • No standard monitoring required
  • Watch for unusual growths if history of cancer

This information is for educational purposes only. Always consult a qualified healthcare provider before starting any peptide protocol.

Pricing

VendorVariantPrice
Limitless Biotech5mg$44.99
Code: PSTACK10Buy
Skye Peptides5mg$39.99
Skye Peptides10mg$64.99
Swiss Chems
FDA warning letter received late 2024
5mg$42.95
Amino Asylum
Reported federal raid in 2025
5mg$29.99BEST
Peptide Sciences
Announced voluntary shutdown
5mg$49.00

Published Research

20 studies indexed(2020–2025)20 reviews

Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review.

Józwiak M, Bauer M, et al.·Pharmaceuticals (Basel)·2025
Review

Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.

Vasireddi N, Hahamyan H, et al.·HSS J·2025
Review

Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing.

McGuire FP, Martinez R, et al.·Curr Rev Musculoskelet Med·2025
Review

Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System.

Sikiric P, Seiwerth S, et al.·Pharmaceuticals (Basel)·2025
Review

Acute Compartment Syndrome and Intra-Abdominal Hypertension, Decompression, Current Pharmacotherapy, and Stable Gastric Pentadecapeptide BPC 157 Solution.

Sikiric P, Seiwerth S, et al.·Pharmaceuticals (Basel)·2025
Review

Injectable Therapeutic Peptides-An Adjunct to Regenerative Medicine and Sports Performance?

DeFoor MT, Dekker TJ·Arthroscopy·2025
Review

The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity.

Sikiric P, Boban Blagaic A, et al.·Pharmaceuticals (Basel)·2024
Review

Stable Gastric Pentadecapeptide BPC 157 and Intestinal Anastomoses Therapy in Rats-A Review.

Bajramagic S, Sever M, et al.·Pharmaceuticals (Basel)·2024
Review

Stable Gastric Pentadecapeptide BPC 157-Possible Novel Therapy of Glaucoma and Other Ocular Conditions.

Sikiric P, Kokot A, et al.·Pharmaceuticals (Basel)·2023
Review

Stable Gastric Pentadecapeptide BPC 157 May Recover Brain-Gut Axis and Gut-Brain Axis Function.

Sikiric P, Gojkovic S, et al.·Pharmaceuticals (Basel)·2023
Review
Showing 10 of 20 studies. Search PubMed for the complete list.